Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study)-Reference-Cited by-同舟云学术

Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study)

Published:2013-10-28 Issue:1 Volume:46 Page:34-45
ISSN:0036-5548
Container-title:Scandinavian Journal of Infectious Diseases
language:en
Short-container-title:Scandinavian Journal of Infectious Diseases

Author:

Fabbiani Massimiliano,Mondi Annalisa,Colafigli Manuela,D’Ettorre Gabriella,Paoletti Francesca,D’Avino Alessandro,Ciccarelli Nicoletta,Sidella Letizia,Murri Rita,Fortuna Serena,Vullo Vincenzo,Cauda Roberto,De Luca Andrea,Di Giambenedetto Simona

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/00365548.2013.840920

Reference40 articles.

1. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients

2. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients

3. Kidney Disease in Patients with HIV Infection and AIDS

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and durability of two‐ vs . three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE cohort;HIV Medicine;2021-07-27

2. Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy;Indian Journal of Hematology and Blood Transfusion;2021-07-03

3. Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy;JAIDS Journal of Acquired Immune Deficiency Syndromes;2021-01-01

4. Efectividad y seguridad del cambio a esquema basado en raltegravir en pacientes con infección por VIH dislipidémicos bajo terapia anti-retroviral en Fundación Arriarán;Revista chilena de infectología;2019-08

5. Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study;International Journal of STD & AIDS;2019-01-10